DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Tele-Pharmacy Intervention to Improve Treatment Adherence

Not Applicable

Completed

Conditions: Hypertension
Hyperlipidemia
Diabetes

Interventions: Behavioral: Telepharmacist intervention

First Posted Date: 2015-07-30

Last Posted Date: 2019-06-06

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 4078

Registration Number: NCT02512276

Locations: 🇺🇸
Harvard Vanguard Medical Associates, Newton, Massachusetts, United States

Personalized Immunotherapeutic for Antibiotic-resistant Infection

Early Phase 1

Completed

Conditions: Immune Deficiency
Infection
Mycoplasma Hominis
Septic Arthritis
Hypogammaglobulinemia

Interventions: Biological: anti-mycoplasma hominis antibodies

First Posted Date: 2015-07-27

Last Posted Date: 2020-01-18

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 1

Registration Number: NCT02508584

Locations: 🇺🇸
Brigham and Women's Hosptial, Boston, Massachusetts, United States

Perioperative Outcomes of Common Methods of Minimally Invasive Contained Tissue Extraction

Completed

Conditions: Hysterectomy

First Posted Date: 2015-07-14

Last Posted Date: 2019-01-25

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 70

Registration Number: NCT02496130

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Faulkner Hospital, Boston, Massachusetts, United States

Characterizing Upper Airway Collapse to Guide Patient Selection for Oral Appliance Therapy for Obstructive Sleep Apnea

Not Applicable

Completed

Conditions: Sleep Apnea, Obstructive

Interventions: Device: Oral appliance
Device: BluePro oral appliance

First Posted Date: 2015-07-03

Last Posted Date: 2022-03-09

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 25

Registration Number: NCT02489591

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC

Phase 2

Completed

Conditions: Lymphangioleiomyomatosis (LAM)

Interventions: Drug: Celecoxib

First Posted Date: 2015-06-30

Last Posted Date: 2022-01-20

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 12

Registration Number: NCT02484664

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Strategies to Reduce Injuries and Develop Confidence in Elders

Phase 3

Completed

Conditions: Accidental Falls
Wounds and Injuries

Interventions: Other: Evidence-based tailored fall prevention
Other: Usual care

First Posted Date: 2015-06-19

Last Posted Date: 2021-03-03

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 5451

Registration Number: NCT02475850

Locations: 🇺🇸
Healthcare Partners, Torrance, California, United States
🇺🇸
Johns Hopkins Medicine, Baltimore, Maryland, United States
🇺🇸
Essentia Health, Duluth, Minnesota, United States

and more 7 locations

Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity in Patients With Obstructive Sleep Apnea - Study B

Phase 2

Completed

Conditions: Sleep Apnea, Obstructive

Interventions: Drug: Desipramine
Drug: Placebo

First Posted Date: 2015-05-06

Last Posted Date: 2017-03-30

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 16

Registration Number: NCT02436031

Locations: 🇺🇸
Sleep Disorders Research Program Brigham and Women's Hospital, Boston, Massachusetts, United States

Effect of Desipramine on Genioglossus Muscle Activity in Healthy Adults Study A

Phase 2

Completed

Conditions: Sleep Apnea, Obstructive

Interventions: Drug: Desipramine
Drug: Placebo

First Posted Date: 2015-04-28

Last Posted Date: 2017-03-30

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 17

Registration Number: NCT02428478

Locations: 🇺🇸
Sleep Disorders Research Program Brigham and Women's Hospital, Boston, Massachusetts, United States

Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

Phase 1

Completed

Conditions: Acute Respiratory Distress Syndrome (ARDS)

Interventions: Drug: Inhaled Carbon Monoxide at 100ppm (4 participants)
Drug: Placebo for Inhaled Carbon Monoxide at 100ppm (2 participants)
Drug: Placebo for Inhaled Carbon Monoxide at 200ppm (2 participants)
Drug: Inhaled Carbon Monoxide at 200ppm (4 participants)

First Posted Date: 2015-04-24

Last Posted Date: 2019-10-17

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 12

Registration Number: NCT02425579

Locations: 🇺🇸
Weill Cornell Medical College/NewYork-Presbyterian, New York, New York, United States
🇺🇸
Duke Univesity Hospital, Durham, North Carolina, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

and more 1 locations

Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.

Phase 1

Completed

Conditions: Sclerosing Cholangitis

Interventions: Biological: Fecal Microbiota Transplantation

First Posted Date: 2015-04-22

Last Posted Date: 2019-08-28

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 10

Registration Number: NCT02424175

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy